The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 12

More JCP Articles

JCP
Treatments and Treatment Predictors in Patients With SUDs and ADHD
Original Research

December 23, 2024

Treatment site explained more of the variation in ADHD treatment provision than patient factors. Higher ADHD symptom severity and sobriety at intake were associated with receiving ADHD treatment.
, , , et al
JCP
Evolving Care and Research Priorities in ADHD
Commentary

December 23, 2024

Surman and Wilens discuss two recent JCP articles highlighting that how ADHD manifests can be heavily influenced by context, as well as individual vulnerabilities and strengths.
,
JCP
Cannabis Use in Pregnancy and ASD or ADHD in Offspring
Clinical and Practical Psychopharmacology

December 23, 2024

Although the number of cannabis-exposed pregnancies (with ASD and ADHD as the outcomes) in world literature is small, cannabis use during pregnancy is a clear marker for adverse neurodevelopmental…
JCP
The Opioid Industry's Legacy: A Generation of Prescribed Suffering
Commentary

December 18, 2024

The authors discuss the influential and far-reaching effects of messaging from the opioid industry on the opioid use epidemic.
,
JCP
Sex Differences in PTSD among US Military Veterans
Brief Report

December 16, 2024

Sex differences in PTSD were attributable to differential exposure to traumatic events such as childhood sexual assault and military sexual trauma and to social factors such as greater loneliness.
, , , et al
JCP
Long-Term Safety and Treatment Effect of Olanzapine/Samidorphan
Original Research

December 4, 2024

During up to 4 years of treatment, the combination of olanzapine/samidorphan was safe and well-tolerated, and patients’ symptoms remained stable.
, , , et al
JCP
Sex Differences in Antidepressant Acceptability
Original Research

December 4, 2024

This study provides evidence of sex differences in antidepressant acceptability, with fluoxetine more acceptable for men than women and the reverse true for paroxetine. Findings suggest the importance of…
, , , et al
JCP
Difficult to Treat Depression: Focus on Approach, Algorithms, and Access
Academic Highlights

November 25, 2024

The Southwest Forum on Difficult to Treat Depression brought together 11 experts to discuss aspects of managing difficult-to-treat depression. This article presents highlights from the forum, covering such topics…
, , , et al
JCP
PTSD and Risk of Suicide Reattempt
Original Research

November 25, 2024

After controlling for comorbid psychiatric conditions and other variables, PTSD was associated with suicide reattempt at 6 months (OR= 2.33) and with rehospitalization in psychiatric settings (OR=2.24) and nonpsychiatric…
, , , et al
JCP
Understanding Meta-Analysis Using Gestational Exposure to Cannabis and Birth Defects
Clinical and Practical Psychopharmacology

November 20, 2024

Dr Andrade discusses strengths and limitations of two recent meta-analyses on birth defects associated with cannabis exposure, with a view to providing readers with a deeper understanding of how…
JCP
MDD and Bipolar Disorder in Black and White Postpartum Women
Original Research

November 20, 2024

No significant difference was observed in the rate of postpartum MDD in Black (40%) versus white (35%) women. However, bipolar disorder significantly differed between Black (19.2%) and white (11.5%)…
, , , et al
JCP
What Is the Role of the Muscarinic Receptor System in Schizophrenia?
Insights

November 19, 2024

In this video, Dr. Correll discusses the role of the muscarinic receptor system in schizophrenia, exploring its impact on cognitive and functional outcomes. He examines the potential for targeting…

Watch the New PsychCase360

Explore two real-world schizophrenia cases

Subscribe to read
more articles

Subscribe